Volume 14, Number 3—March 2008
Research
Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City
Table 3
Comparison of coexisting conditions and concomitant medications with body site of nontuberculous mycobacteria (NTM) disease, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003
Site of NTM disease | % Patients receiving concomitant medications (n = 79) |
||||
---|---|---|---|---|---|
Systemic steroids | Immunosuppressants | Chemotherapeutics | Immunomodulators | None | |
Blood (n = 7) | 50 | 33 | 50 | 17 | 17 |
Respiratory tract (n = 81) | 26 | 13 | 2 | 4 | 70 |
Skin and soft tissue, surgical sites (n = 21) | 17 | 17 | 8 | 8 | 75 |
All† | 25 | 15 | 6 | 5 | 66 |
*Defined as diabetes, chronic renal failure and/or rheumatologic disease.
†Includes 2 patients with disseminated disease following bone marrow transplantation, 1 patient with central nervous system disease receiving steroids, 1 patient with gastrointestinal disease, and 2 patients with lymph node disease/cancer.